Evolving indications and long-term oncological outcomes of risk-reducing bilateral nipple-sparing mastectomy.

Stephen R GrobmyerH J PedersonS A ValenteZ Al-HilliD RadfordR DjohanR YetmanC EngJ P Crowe

Published in: BJS open (2018)

The use of bilateral NSM for breast cancer risk reduction is increasing and the indications have evolved over the past 16 years. These excellent long-term oncological results suggest that bilateral NSM is a good option for surgical breast cancer risk reduction.

Keyphrases

breast cancer risk
robot assisted
case report
rectal cancer
radical prostatectomy
breast reconstruction
prostate cancer
metabolic syndrome